glp-1 atrial fibrillation

glp-1 atrial fibrillation Abstract 4368472: Glucagon-Like Peptide 1 Mediated Reduction in Risk Is Independent of Weight Loss GLP-1 receptor agonists (GLP-1RAs): cardiovascular

Name: glp-1 atrial fibrillation Abstract 4368472: Glucagon-Like Peptide 1 Mediated Reduction in Risk Is Independent of Weight Loss GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Brand: virelaev.store
SKU: 72113220536
Price: 25.02 USD
Availability: InStock
Rating: 4.297000000000001 (18 reviews)

SKU: 72113220536

4.3

EUR25.02 EUR75.02

Pay in 4 interest-free payments of $6.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Description

Annually thereafter: Continue monitoring vitamin D, B12, iron, and calcium markers

Can you explain the methodology for your research

Ispoglou T, White H, Preston T, McElhone S, McKenna J, Hind K

Author: Sindhya Valloppillil

The available human data is mainly from small observational and retrospective studies showing that GLP-1 drugs appear safe and well tolerated in people with MS when used for diabetes or weight loss

For patients with diabetes who are also taking insulin or sulfonylureas, there is an increased risk of hypoglycaemia